Illumina Inc (ILMN)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: LABORATORY ANALYTICAL INSTRUMENTS

5200 ILLUMINA WAY SAN DIEGO, CA 92122

Develops and markets next-generation tools for the large-scale analysis of genetic variation and function. The company's tools help researchers gain information that could be used to enhance drug discovery, allow diseases to be detected earlier and permit better choices of drugs for patients.

Data based on most recent fiscal year report
Market Cap33.571 Billion Shares Outstanding146 Million Avg Volume1.465 Million
1-Yr BETA vs S&P TR Current Ratio3.99 Quick Ratio3.55
View SEC Filings from ILMN instead.
Q1 2019 All Institutions Hedge Funds 1
To trade ILMN now:
Filers who had this stock in their top 10: 21 4 (0.41%)
13F Filers holding this stock: 842 82 (8.36%)
Aggregate 13F shares on 03/31/2019: 131.752 Million 5.697 Million
Aggregate 13F shares on 12/31/2018: 132.963 Million 5.128 Million
Percent change: -0.91% 11.09%
Funds creating new positions: 103 15
Funds Adding to an existing position: 324 24
Funds closing out their position: 61 16
Funds reducing their position: 280 32
Heat Map Ranking for 03/31/2019 66
Heat Map Ranking for 12/31/2018 27
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ILMN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

38.2 Thousand total shares from 26 transactions

Exercise Derivative Conversion (M)

16 Thousand total shares from 3 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

RASTETTER WILLIAM H

  • Director
0 2019-05-22 0

DORSA CAROLINE

  • Director
0 2019-05-21 0

RONAGHI MOSTAFA SVP & CTO

  • Officer
77,414 2019-05-15 12

SIEGEL SUSAN E

  • Director
4,971 2019-05-15 2

ARNOLD FRANCES

  • Director
10,159 2019-05-13 1

OSTADAN OMEAD SVP MKTG, PROD & STRAT PLAN

  • Officer
13,205 2019-05-10 9

FLATLEY JAY T

  • Director
289,816 2019-05-08 19

GUTHART GARY S PRESIDENT & CEO

  • Officer
  • Director
364,230 2019-05-06 0

EPSTEIN ROBERT S

  • Director
0 2019-05-03 11

POSARD MATTHEW L.

  • Director
114,924 2019-05-02 0

DADSWELL CHARLES SVP & GENERAL COUNSEL

  • Officer
8,086 2019-05-01 9

DESOUZA FRANCIS A PRESIDENT AND CEO

  • Officer
  • Director
70,936 2019-05-01 17

HUBER JEFF

  • Director
79,740 2019-05-01 0

BRADBURY DANIEL

  • Director
51,323 2019-03-29 0

THOMPSON JOHN WENDELL

  • Director
28,345 2019-03-14 0

HOYT AIMEE L SVP, CHIEF PEOPLE OFFICER

  • Officer
2,297 2019-02-26 3

VAN OENE MARK SVP CHIEF COMMERCIAL OFFICER

  • Officer
14,834 2019-02-12 4

RAGUSA ROBERT P SVP, GLOBAL QUALITY & OPS

  • Officer
14,048 2019-02-12 2

HAMPTON MALCOLM GARRET SVP CLINICAL GENOMICS GROUP

  • Officer
7,774 2019-01-09 3

SAMAD SAM SVP AND CFO

  • Officer
4,612 2019-01-07 3

WALT DAVID R

1,220,040 2019-01-02 0

STAPLEY MARC

8,572 2019-01-02 7

MCCOMB JOEL

  • Director
0 2018-12-14 0

MCGINNIS KAREN K VP, CHIEF ACCOUNTING OFFICER

  • Officer
2,240 2018-12-11 2

GOLDSTEIN JACK

  • Director
149,215 2018-11-30 0

EASTHAM KARIN

  • Director
10,838 2018-11-06 1

WHITFIELD ROY A

  • Director
201,750 2018-09-27 0

FLATLEY JAY T

  • Director
400,204 2018-09-12 19

HENRY CHRISTIAN O

  • Director
0 2018-08-13 0

BOWMAN A BLAINE

  • Director
16,814 2018-05-22 0

SCHILLER PHILIP W

  • Director
7,787 2018-05-22 0

KLAUSNER RICHARD

  • Director
No longer subject to file 2018-03-05 0

GRINT PAUL C CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
599 2017-12-08 0

BOUCHARD MICHEL CHIEF ACCOUNTING OFFICER

  • Officer
9,538 2017-11-06 0

ORPIN TRISTAN EVP CLINICAL GENOMICS

  • Officer
118,259 2016-11-07 0

BIANCHI PAUL L SR. VP, HUMAN RESOURCES

  • Officer
65,660 2016-04-18 0

NACLERIO NICHOLAS SR VP, CORPORATE DEVELOPMENT

  • Officer
30,020 2016-03-21 0

MOELLER GERALD

  • Director
17,647 2015-03-31 0

HEATH GREGORY SR VP & GENERAL MANAGER

  • Officer
26,740 2013-12-17 0

LEWIS MARK L SR VP & GENERAL MANAGER

  • Officer
44,837 2013-11-01 0

CABOU CHRISTIAN SR VP & GENERAL COUNSEL

  • Officer
46,553 2013-04-23 0

STUELPNAGEL JOHN R SR VP AND COO

  • Officer
  • Director
337,836 2008-03-27 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

RONAGHI MOSTAFA - Officer SVP & CTO

2019-05-15 S 3,182 $306.84 d 78,548 77,414.00 direct

RONAGHI MOSTAFA - Officer SVP & CTO

2019-05-15 S 1,180 $303.43 d 85,834 77,414.00 direct

RONAGHI MOSTAFA - Officer SVP & CTO

2019-05-15 M 10,000 d 44,000 77,414.00 direct

RONAGHI MOSTAFA - Officer SVP & CTO

2019-05-15 S 1,600 $305.29 d 81,730 77,414.00 direct

RONAGHI MOSTAFA - Officer SVP & CTO

2019-05-15 S 400 $301.82 d 87,014 77,414.00 direct

RONAGHI MOSTAFA - Officer SVP & CTO

2019-05-15 S 1,134 $307.54 d 77,414 77,414.00 direct

RONAGHI MOSTAFA - Officer SVP & CTO

2019-05-15 S 2,504 $304.53 d 83,330 77,414.00 direct

RONAGHI MOSTAFA - Officer SVP & CTO

2019-05-15 M 10,000 $69.34 a 87,414 77,414.00 direct

ARNOLD FRANCES - Director

2019-05-13 S 1,503 $307.95 d 10,159 10,159.00 direct

OSTADAN OMEAD - Officer SVP MKTG, PROD & STRAT PLAN

2019-05-10 S 1,260 $315.32 d 13,205 13,205.00 direct

FLATLEY JAY T - Director

2019-05-08 S 3,300 $318.59 d 285,816 289,816.00 direct

DADSWELL CHARLES - Officer SVP & GENERAL COUNSEL

2019-05-01 S 124 $311.77 d 8,086 8,086.00 direct

DESOUZA FRANCIS A - Director - Officer PRESIDENT AND CEO

2019-05-01 S 1,100 $309.42 d 72,836 70,936.00 direct

EPSTEIN ROBERT S - Director

2019-05-01 S 1,372 $311.23 d 3,456 3,256.00 direct

EPSTEIN ROBERT S - Director

2019-05-01 M 5,000 $51.17 a 8,256 3,256.00 direct

DESOUZA FRANCIS A - Director - Officer PRESIDENT AND CEO

2019-05-01 S 200 $311.89 d 70,936 70,936.00 direct

EPSTEIN ROBERT S - Director

2019-05-01 M 5,000 d 0 3,256.00 direct

EPSTEIN ROBERT S - Director

2019-05-01 S 2,228 $310.29 d 4,828 3,256.00 direct

DESOUZA FRANCIS A - Director - Officer PRESIDENT AND CEO

2019-05-01 S 1,700 $310.17 d 71,136 70,936.00 direct

EPSTEIN ROBERT S - Director

2019-05-01 S 200 $312.17 d 3,256 3,256.00 direct

EPSTEIN ROBERT S - Director

2019-05-01 S 1,200 $309.51 d 7,056 3,256.00 direct

FLATLEY JAY T - Director

2019-04-24 S 3,300 $321.96 d 289,116 293,116.00 direct

FLATLEY JAY T - Director

2019-04-10 S 3,300 $317.01 d 331,668 335,668.00 direct

DESOUZA FRANCIS A - Director - Officer PRESIDENT AND CEO

2019-04-01 S 300 $317.64 d 73,746 73,746.00 direct

DESOUZA FRANCIS A - Director - Officer PRESIDENT AND CEO

2019-04-01 S 1,100 $314.86 d 75,646 73,746.00 direct

EPSTEIN ROBERT S - Director

2019-04-01 S 1,000 $314.45 d 3,256 3,256.00 direct

DESOUZA FRANCIS A - Director - Officer PRESIDENT AND CEO

2019-04-01 S 700 $316.94 d 74,046 73,746.00 direct

DADSWELL CHARLES - Officer SVP & GENERAL COUNSEL

2019-04-01 S 124 $314.45 d 8,210 8,210.00 direct

EPSTEIN ROBERT S - Director

2019-04-01 M 1,000 $51.17 a 4,256 3,256.00 direct

DESOUZA FRANCIS A - Director - Officer PRESIDENT AND CEO

2019-04-01 S 900 $315.88 d 74,746 73,746.00 direct

EPSTEIN ROBERT S - Director

2019-04-01 M 1,000 d 5,000 3,256.00 direct

FLATLEY JAY T - Director

2019-03-27 S 3,300 $306.93 d 334,968 338,968.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments